Anna D. Garrett, PharmD, BCPS
Anna D. Garrett is a clinical pharmacist and president of Dr. Anna Garrett (www.drannagarrett.com). Her mission is to help women in midlife maximize their mojo! Contact her at [email protected]
Oral Anticoagulant Safety, Apixaban, Statins and VTE
According to a recent report from the Institute of Safe Medication practices (ISMP), FDA received 34,765 adverse drug event reports for oral anticoagulants in 2015.
USPSTF updates recommendations for aspirin use
The guidelines, which update the group's 2007 and 2009 recommendations, are published in the "Annals of Internal Medicine."
Fall-related ICH incidence in elderly on warfarin
A study of nearly 32,000 aging veterans revealed the unsuspected vulnerability of this population.
ICH volume smaller with DOACs than with warfarin
A study of 344 patients with anticoagulant-associated ICH found that when data were adjusted for confounding factors, warfarin use remained independently associated with larger ICH volumes.
Antithrombotic therapy to prevent migraine attacks after ASD closure
Clopidogrel therapy can make a difference after ASD closures.
Pre-op anticoagulation reduces VTE risk in cancer patients
Researchers found that rates of DVT and PE were significantly lower among patients who received preoperative chemoprophylaxis than in those who did not.
Andexanet quickly reverses factor Xa inhibitor activity for DOACs
Andexanet alpha is designed to reverse the anticoagulant effects of factor Xa inhibitors.